w 7 has been researched along with perphenazine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conroy, MC; Kennedy, JA; Thueson, DO; Wright, CD | 1 |
Tallant, EA; Wallace, RW | 1 |
Furuya, A; Kamada, A; Nishihata, T; Suzuka, T | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
4 other study(ies) available for w 7 and perphenazine
Article | Year |
---|---|
Specific inhibition of phorbol ester and DiC8-induced histamine release from human basophils by the protein kinase C inhibitors, H-7 and H-9.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Basophils; Calcimycin; Calmodulin; Diglycerides; Glycerides; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Isoquinolines; Kinetics; Perphenazine; Piperazines; Protein Kinase C; Sulfonamides; Tetradecanoylphorbol Acetate | 1987 |
Calmodulin antagonists elevate the levels of 32P-labeled polyphosphoinositides in human platelets.
Topics: Blood Platelets; Calmodulin; Chlorpromazine; Humans; Kinetics; Perphenazine; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phosphatidylinositols; Promazine; Sulfonamides; Tamoxifen; Trifluoperazine | 1985 |
Effects of phenothiazines and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide on rat colonic absorption of cefmetazole.
Topics: Animals; Biological Availability; Calmodulin; Cefmetazole; Cephamycins; Chromatography, High Pressure Liquid; Colon; Intestinal Absorption; Male; Perphenazine; Phenothiazines; Promethazine; Rats; Rats, Inbred Strains; Sulfonamides; Trifluoperazine | 1986 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |